Zobrazeno 1 - 10
of 236
pro vyhledávání: '"translocation renal cell carcinoma"'
Autor:
Kenta Takahashi, Renpei Kato, Daiki Ikarashi, Tomohiko Matsuura, Shigekatsu Maekawa, Mitsugu Kanehira, Ryo Takata, Jun Sugimura, Takaya Abe, Wataru Obara
Publikováno v:
IJU Case Reports, Vol 7, Iss 2, Pp 131-135 (2024)
Introduction Patients with translocation renal cell carcinoma (tRCC) have a poor prognosis without standardized treatment. Case presentation The first case was of a 72‐year‐old woman who underwent robot‐assisted partial nephrectomy for a left r
Externí odkaz:
https://doaj.org/article/1fb457a5a7234ea6b2cc6550f437e6b0
Autor:
Shunsuke Fujisawa, Junya Furukawa, Takuto Hara, Keiske Okada, Kouji Chiba, Yuzo Nakano, Toshiki Hyodo, Yoji Nagashima, Masato Fujisawa
Publikováno v:
Clinical Case Reports, Vol 11, Iss 11, Pp n/a-n/a (2023)
Key Clinical Message Renal cell carcinoma as a secondary malignant neoplasm is relatively rare; however, the possibility of secondary renal cell carcinoma following chemoradiotherapy for childhood nephroblastoma should be considered. Abstract The occ
Externí odkaz:
https://doaj.org/article/0c86693b01204a1e83ab7f08b0cb58ca
Publikováno v:
Frontiers in Medicine, Vol 10 (2023)
BackgroundXp11.2 translocation/TFE3 gene fusion associated with renal cell carcinoma (Xp11.2 RCC) exhibits unique biological characteristics and is associated with an increased incidence of tumor thrombosis, lymph node metastasis, and advanced diseas
Externí odkaz:
https://doaj.org/article/04c7e37b61b747748e023bc72a7b8fb3
Publikováno v:
Frontiers in Pediatrics, Vol 11 (2023)
RCC accounts for only 0.1%–0.3% of all kidney tumors and 2%–6% of malignant kidney tumors in children. Accounting for approximately one-third of the total number of cases in children and adolescents with RCC, Xp11.2 tRCC is the most common subtyp
Externí odkaz:
https://doaj.org/article/6e095ff89da346938fd467e9335f0f48
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
BackgroundXp11.2 translocation renal cell carcinoma (Xp11.2 tRCC) is a group of rare and highly heterogeneous renal cell carcinoma (RCC). The translocation involving TFE3 and different fusion partners lead to overexpression of the chimeric protein. T
Externí odkaz:
https://doaj.org/article/68eea2b228694689a0b9627967c96624
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Renal cell carcinoma (RCC) associated with Xp11.2 translocation/TFE3 gene fusions is a rare subtype of renal tumor. This entity predominantly occurs in juveniles, but rarely in adults. Xp11.2 translocation RCC (tRCC) patients with lymph node or organ
Externí odkaz:
https://doaj.org/article/8bf50322613f47b7abea12777ec38523
Autor:
Ajaykumar Chandrabhan Singh, Mahendra Pal, Akhil Kapoor, Nandini Menon, Kumar Prabhash, Vanita Noronha, Ganesh Bakshi, Gagan Prakash, Santosh Menon, Nilesh Sable, Devanshi Kalra, Sheetal Kulkarni, Amit Joshi
Publikováno v:
South Asian Journal of Cancer, Vol 10, Iss 02, Pp 92-96 (2021)
Introduction TFE Translocation renal cell carcinoma (TRCC) represents 1 to 5% of all cases of renal cell carcinoma, with the highest frequency among children and young adults. Management of these tumors is not very well defined in literature. Althoug
Externí odkaz:
https://doaj.org/article/25b1ec30f24645558bf2c0248427ad43
Publikováno v:
Cancer Management and Research, Vol Volume 13, Pp 2419-2431 (2021)
Yiqi Zhu,1,* Xiaohong Pu,2,* Xiang Dong,3 Changwei Ji,1 Hongqian Guo,1 Dongmei Li,4,5 Xiaozhi Zhao,1 Weidong Gan1 1Department of Urology, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, Jiangsu, Peo
Externí odkaz:
https://doaj.org/article/57da00247a9e4dfe917ad4ceba2c5305